(WBA Unsec: B1 CW Neg/BB- CW Neg)
- exp. $500m under the Boots spin-off has been dropped. Size on €/£ tranche remains unchanged at $750/$500m eqv. Unclear if loans will be upsized for short-fall.
- It will issue on B1/B+/BB as it pushes most of the financing debt onto the better performing UK retailer (core business is US Walgreens).
- $-long end remains confident on triggering downgrades/CoC at 101: 44s at $96.5, +25pts YTD.